Pharmacy + Medication Error Cases: Co-Defendant Strategy

By John Mahoney · May 2026 · 13 min read

Medication-error cases produce some of the highest-liability fact patterns in medical malpractice: wrong drug, wrong dose, wrong route, wrong patient, wrong concentration. The Institute for Safe Medication Practices (ISMP), the Joint Commission, and CMS have all published frameworks for preventing medication errors at every step of the medication-use process — prescribing, transcribing, dispensing, administration, and monitoring. The framework is well-established, but the question of who should be sued — the prescribing physician, the hospital, the dispensing pharmacy, the manufacturer — is often the central strategic question at intake.

This guide walks through the co-defendant analysis: when to add the pharmacy as a separate defendant, the vicarious-liability framework that applies to hospital-employed pharmacy staff vs. contract pharmacy services, the medication-administration records that document the actual error, and the MAR-vs-eMAR analysis and BCMA scan-log discovery that establishes the failure mode.

The Medication-Use Process: Five Steps, Five Potential Defendants

Medication errors can occur at any of five steps in the medication-use process. Each step implicates a different defendant or combination of defendants.

Prescribing

Prescribing errors — wrong drug for the indication, wrong dose for the patient's weight or renal function, failure to check for interactions, failure to check allergies — implicate the prescribing physician and (under vicarious liability) the physician's employer. CPOE (computerized provider order entry) systems are now standard in inpatient and outpatient settings; the CPOE record, including any alerts that fired and any documented overrides, is critical evidence.

Transcribing and order verification

In inpatient settings, the pharmacy reviews and verifies physician orders before dispensing. The pharmacist's order-verification step is intended to catch prescribing errors — wrong dose, wrong route, interactions, allergies. A pharmacist who verified an order containing a clinically significant error breached the standard of care for pharmacy practice. The order-verification record is captured in the pharmacy information system.

Dispensing

Dispensing errors include wrong drug pulled from the shelf, wrong concentration of an injectable, look-alike/sound-alike (LASA) drug confusion, and labeling errors. The dispensing record — captured in the pharmacy information system and the automated dispensing cabinet (ADC) logs — documents the actual product dispensed and the dispensing pharmacist or technician.

Administration

Administration errors are the most common medication-error category. Wrong patient, wrong dose pulled from the ADC, wrong route, wrong time, missed dose. The medication-administration record (MAR) — paper or electronic — and the BCMA (barcode medication administration) scan log document the administration event.

Monitoring

Monitoring failures — failure to check creatinine before nephrotoxic dosing, failure to monitor INR on warfarin, failure to recognize an adverse drug reaction — implicate the prescribing physician and the inpatient care team. Lab-result acknowledgment timestamps and progress-note documentation are the relevant records.

When to Add the Pharmacy as a Co-Defendant

The decision to add the pharmacy as a co-defendant turns on (a) where in the process the error occurred, (b) the employment status of the pharmacy staff, and (c) the financial and procedural implications of multiple defendants.

Inpatient hospital pharmacy

In most hospitals, the pharmacy department is operated by hospital-employed pharmacists. Errors at the order-verification, dispensing, or compounding stages are typically captured under the hospital's vicarious liability, and a separate pharmacy claim may not be procedurally necessary. The hospital is named as the defendant for the pharmacist's negligence. In some institutions, the pharmacy is operated by a contracted service (often a major retail pharmacy chain operating under contract); in those cases, the pharmacy service is a separate corporate defendant.

Retail and mail-order pharmacy

Retail pharmacy errors — wrong drug filled, wrong dose strength, mislabeling — implicate the pharmacy corporation directly. The dispensing pharmacist is rarely named individually; the corporate pharmacy is the defendant. State pharmacy-practice statutes and the pharmacist's duty of care to the patient are the legal framework.

Long-term care and infusion pharmacy

Long-term care pharmacies dispense to nursing homes and assisted-living facilities. Infusion pharmacies compound and dispense injectable medications for outpatient infusion. Both are typically separate corporate entities and are appropriately named as defendants when the error occurred at their level. Compounding-pharmacy errors — particularly involving sterile injectables — are a recurring high-liability area.

Manufacturer (product-liability overlay)

When the error involves a defective product, packaging confusion, or inadequate labeling at the manufacturer level, the manufacturer is named under a product-liability theory. The classic example is look-alike/sound-alike (LASA) errors driven by similar packaging — the manufacturer's labeling and packaging decisions are part of the causal chain. Manufacturer defendants are typically added in cases where the dispensing or administration error was foreseeable given the packaging.

Vicarious Liability: The Apparent-Agency and Captive-Pharmacy Frameworks

Vicarious liability is central to medication-error cases because the human who made the actual error — the dispensing pharmacist, the administering nurse — is often not the deep-pocket defendant.

Hospital vicarious liability

Hospitals are vicariously liable for negligence by employed staff under traditional respondeat superior. The breadth of "employed" varies by jurisdiction: pharmacists are typically W-2 employees of the hospital, but ED physicians, hospitalists, and anesthesiologists are often contracted through outside groups. Many jurisdictions extend apparent-agency liability to contracted physicians when the patient reasonably believed the physician was a hospital employee — the "holding out" doctrine. The applicability of apparent agency in medication-error cases involving contracted prescribers is jurisdiction-specific.

Retail pharmacy vicarious liability

Retail pharmacy chains are vicariously liable for the negligence of their employed pharmacists. Independent contractor defenses are rare in retail pharmacy because pharmacists are typically employees of the chain.

Contracted pharmacy services

When a hospital outsources pharmacy operations to a contracted service, the contractual structure determines whether the hospital, the contracted service, or both are vicariously liable for the pharmacist's negligence. The service agreement is discoverable and the indemnification and insurance provisions are relevant to the strategic decision about which defendants to name.

MAR vs eMAR: What the Records Actually Show

The medication administration record (MAR) is the document of last resort for administration events. The transition from paper MAR to electronic MAR (eMAR) has changed both the evidentiary quality and the failure modes.

Paper MAR

Paper MARs are still used in some long-term care and small-facility settings. The paper MAR is typically a 24-hour or shift-based document with the nurse's initials confirming each administration. Paper MARs are vulnerable to "pre-charting" — entries made before the actual administration — and to retrospective fill-in after a missed dose is discovered. The handwriting and the initials are reviewable.

Electronic MAR

The eMAR captures the administration event with a timestamp, the administering nurse, and (typically) a BCMA scan of both the patient wristband and the medication. The eMAR is harder to falsify than the paper MAR but can still be inaccurate — particularly when the administering nurse uses a workaround (e.g., scanning a patient barcode in advance, then administering the medication later).

BCMA scan log

The BCMA scan log is the most objective record of medication administration. Each scan event captures the time, the scanner (the handheld device), the patient barcode scanned, the medication barcode scanned, and whether the scan was a match or a discrepancy. BCMA discrepancy alerts — where the scanned medication did not match the ordered medication — are critical: if the alert fired and was overridden, the override is captured in the log.

The "override" pattern

A recurring fact pattern is the BCMA alert that fired indicating a discrepancy, was overridden by the nurse, and the wrong medication was administered. The override timestamp, the override reason entered (if any), and the nurse's documented justification are the evidence. The override pattern is one of the most reliable indicators of administration error.

Discovery Strategy: What to Subpoena

The records that matter most are not produced under a routine release. Subpoena specifically:

• The CPOE order record — the original order, any alerts that fired during ordering, and any overrides documented
• The pharmacy information system record — the pharmacist's order-verification step, including any interventions or queries
• The automated dispensing cabinet log — every withdrawal, override, and discrepancy on the ADC during the relevant period
• The BCMA scan log — every scan event for the patient during the admission, with alerts and override responses
• The eMAR with audit trail — administration documentation including the audit trail showing any post-event amendments
• The pharmacy compounding record (in cases involving compounded medications) — the compounding pharmacist, the batch record, and the master formulation
• Drug-product labeling and packaging — for LASA cases, the actual labels and packaging in use at the time
• Hospital pharmacy P&T committee records — formulary decisions and prior medication-error reports (typically protected under peer-review privilege)
• Incident report and root-cause analysis — typically peer-review privileged, but the discoverability of the underlying clinical records is preserved
• Pharmacist licensure and competency records — state-board records, prior disciplinary actions

Expert Witness Strategy

Pharmacy expert

For order-verification or dispensing errors, retain a clinical pharmacist with hospital-pharmacy experience. The pharmacy expert addresses the order-verification standard, the dispensing standard, and the institutional pharmacy-practice standards. For retail pharmacy cases, retain a community-pharmacy expert with current dispensing-practice experience.

Nursing expert

For administration errors, retain a nursing expert with current experience in the relevant setting (med-surg, ICU, long-term care, or pediatrics as appropriate). The nursing expert addresses the BCMA standard, the five-rights protocol (right patient, right drug, right dose, right route, right time), and the institutional medication-administration standards.

Prescribing-physician expert

For prescribing errors, retain a physician expert in the relevant specialty. The expert addresses the standard for medication selection, dosing, monitoring, and the integration of the EHR clinical decision-support alerts.

Causation expert

For causation, retain an expert who can opine on the relationship between the medication error and the resulting injury. The specialty depends on the injury — toxicology, critical care, neurology, or other.

Common Defense Moves and Counters

"The pharmacist verified the order in good faith based on the prescriber's judgment"

Defense will argue the pharmacist was entitled to rely on the prescriber's clinical judgment. The counter is the pharmacist's independent duty under state pharmacy-practice statutes and institutional pharmacy-practice standards to identify clinically significant errors — wrong dose for a renally-impaired patient, contraindicated drug given a documented allergy, dangerous interaction with an existing medication. The order-verification step exists precisely to catch prescribing errors.

"The BCMA alert was overridden for legitimate clinical reasons"

Defense will argue the BCMA alert was overridden in good faith because alerts fire frequently and have a high false-positive rate. The counter is the specific alert that fired — its content, the override reason entered (or not), and whether the override was consistent with documented clinical practice. Alert-fatigue arguments do not relieve the nurse of the duty to verify before administering.

"The error did not cause the injury"

Defense will challenge causation, particularly when the patient had multiple co-morbidities. The counter is the expert opinion on the specific causal pathway from the medication error to the injury — the wrong dose of insulin caused the hypoglycemia, which caused the documented neurologic event; the missed antibiotic dose caused the documented worsening of the infection.

"The hospital and the pharmacy are separate corporate entities"

In cases involving contracted pharmacy services, defense may argue the hospital is not liable for the contracted pharmacy's negligence. The counter is the service agreement, the apparent-agency framework, and the joint operational integration that may support a non-delegable-duty theory.

Co-Defendant Strategic Considerations

Adding the pharmacy as a co-defendant has practical implications beyond the theoretical liability framework.

Insurance coverage

The hospital and the contracted pharmacy typically have separate insurance carriers. Naming both ensures both policies are in play. The pharmacy's professional-liability coverage is typically substantial.

Indemnification clauses

Service agreements between hospitals and contracted pharmacies typically include indemnification clauses. The discoverable contract may determine which carrier ultimately funds the settlement.

Apportionment of fault

In comparative-fault jurisdictions, the jury apportions fault among the named defendants. Adding multiple defendants does not increase the total recoverable damages but may shift the apportionment toward the deeper-pocket defendant.

Procedural complexity

Multiple defendants means multiple sets of pre-suit notice, multiple affidavit-of-merit requirements (in states requiring them), multiple defense counsel, and multiple expert depositions. The procedural cost is real and should be weighed against the strategic benefit.

Bottom Line

Medication-error cases turn on the five-step medication-use process and the records each step generates. The strategic question of which defendants to name — prescriber, hospital, pharmacy, manufacturer — depends on where in the process the error occurred and on the corporate structure of the pharmacy operation. The records that establish the error are not in the routine production: the CPOE alerts, the pharmacy-verification log, the ADC withdrawals, the BCMA scan log, and the eMAR audit trail all require targeted discovery. Plaintiff attorneys who name the right defendants, subpoena the right records, and retain the right expert mix — pharmacy, nursing, prescribing-physician, and causation — consistently produce medication-error cases that resolve at value.

Questions? Contact us at [email protected]